Contract Research Organizations
•37 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (37)
| Company | Market Cap | Price |
|---|---|---|
|
TMO
Thermo Fisher Scientific Inc.
Thermo Fisher provides contract research organization services (CRO capabilities) for outsourced drug development.
|
$192.62B |
$513.04
+0.97%
|
|
IQV
IQVIA Holdings Inc.
IQVIA operates as outsourced drug development and clinical research services akin to a CRO.
|
$30.24B |
$178.10
+2.38%
|
|
LH
Labcorp Holdings Inc.
Labcorp functions as aContract Research Organization offering outsourced drug development and regulatory support services.
|
$23.28B |
$280.87
-0.75%
|
|
MEDP
Medpace Holdings, Inc.
Medpace's core business is a specialized full-service CRO delivering Phase I–IV clinical development services.
|
$13.12B |
$465.86
+0.10%
|
|
CRL
Charles River Laboratories International, Inc.
CRL operates as a contract research organization, outsourcing preclinical drug development services.
|
$8.84B |
$180.00
+2.45%
|
|
ICLR
ICON Public Limited Company
Directly describes ICON's outsourced drug development and management services as a Contract Research Organization.
|
$8.57B |
$110.33
+1.50%
|
|
OLED
Universal Display Corporation
Contract research services via Adesis subsidiary.
|
$4.83B |
$101.55
-2.11%
|
|
RXRX
Recursion Pharmaceuticals, Inc.
Collaborations with pharma partners and outsourced discovery work resemble a CRO-type service model.
|
$1.90B |
$3.63
+2.54%
|
|
AZTA
Azenta, Inc.
Genewiz genomic sequencing and broader SMS/Multiomics services align with Contract Research Organizations.
|
$1.15B |
$25.12
+2.38%
|
|
FTRE
Fortrea Holdings Inc.
Fortrea operates as a standalone contract research organization providing outsourced clinical development services.
|
$959.11M |
$10.36
-1.15%
|
|
ABSI
Absci Corporation
Partnership-driven model for drug creation aligns with Contract Research Organizations (CRO)-like outsourced R&D services.
|
$559.21M |
$3.87
+3.34%
|
|
FLGT
Fulgent Genetics, Inc.
Contract Research Organization services for bioPharma.
|
$432.46M |
$14.02
+1.67%
|
|
DNA
Ginkgo Bioworks Holdings, Inc.
Contract Research Organizations as a historic and current service model.
|
$405.35M |
$6.71
+0.22%
|
|
ACRS
Aclaris Therapeutics, Inc.
The company reports contract research revenue, indicating provided drug development services.
|
$335.87M |
$3.10
+2.14%
|
|
QTRX
Quanterix Corporation
Offers contract research services via its Accelerator Lab, aligning with CRO-type activities.
|
$273.73M |
$5.85
-0.34%
|
|
LFCR
Lifecore Biomedical, Inc.
Lifecore's development pipeline and development services align with Contract Research Organizations.
|
$261.40M |
$7.06
+1.00%
|
|
CLPT
ClearPoint Neuro, Inc.
Biologics and drug-delivery consulting capabilities (GLP expansion, preclinical support) align with CRO-like outsourced development services.
|
$254.14M |
$8.93
+1.08%
|
|
BNR
Burning Rock Biotech Limited
Biopharma services segment indicates outsourced R&D, clinical testing, and development support.
|
$236.69M |
$22.29
-5.31%
|
|
IMRX
Immuneering Corporation
The company relies on contract research organizations for preclinical/clinical testing and trials.
|
$187.77M |
$5.16
+4.24%
|
|
MXCT
MaxCyte, Inc.
Contract Research Organizations tag reflects MaxCyte's CRO-like gene editing assessment services through SeQure Dx.
|
$164.17M |
$1.55
+0.65%
|
|
BDSX
Biodesix, Inc.
Biodesix's Development Services revenue aligns with CRO-like outsourced diagnostic testing for partners.
|
$121.72M |
$15.21
-1.87%
|
|
FBIO
Fortress Biotech, Inc.
Fortress engages in outsourced development activities and governance across its portfolio, aligning with CRO services.
|
$92.24M |
$3.10
+1.47%
|
|
CBUS
Cibus, Inc.
Reported contract research revenue indicates direct R&D services provided to clients alongside platform licensing.
|
$91.66M |
$1.68
+5.66%
|
|
CSBR
Champions Oncology, Inc.
Company provides outsourced drug development and preclinical/clinical research services to biopharma (CRO-style).
|
$82.73M |
$6.11
+1.75%
|
|
AKYA
Akoya Biosciences, Inc.
Contract Research Organizations alignment due to outsourced lab services and clinical testing capabilities.
|
$64.26M |
$1.29
|
|
ABVC
ABVC BioPharma, Inc.
BioKey provides Contract Research Organization services, including API characterization, formulation development, and regulatory submissions.
|
$35.24M |
$1.45
+1.76%
|
|
PLUR
Pluri Inc.
Contract research and development services complement CDMO capabilities and scale the pipeline.
|
$33.04M |
$3.71
+5.10%
|
|
RADX
Radiopharm Theranostics Limited
Company provides external development services for others, akin to CRO activities.
|
$31.82M |
$4.79
-1.64%
|
|
VNRX
VolitionRx Limited
Nu.Q Discover provides epigenetic profiling services to drug developers, akin to Contract Research Organizations.
|
$30.74M |
$0.36
+26.22%
|
|
SEED
Origin Agritech Limited
Origin provides breeding services and collaborative R&D through a service consortium, aligning with Contract Research Organizations.
|
$12.74M |
$1.03
+1.47%
|
|
NOTV
Inotiv, Inc.
Inotiv operates as a CRO delivering nonclinical drug discovery and development services, aligning with the Contract Research Organizations tag.
|
$12.33M |
$0.36
+26.63%
|
|
BFRG
Bullfrog AI Holdings, Inc. Common Stock
Engages in external collaborations/partnerships to provide AI-driven drug development services, akin to CRO-type engagements.
|
$6.15M |
$0.62
+9.60%
|
|
APM
Aptorum Group Limited
Aptorum plans near-term revenue from biopharma services via the DiamiR merger, aligning with contract research/Development outsourcing.
|
$4.63M |
$0.80
+0.78%
|
|
POAI
Predictive Oncology Inc.
Provides outsourced drug discovery services (wet lab, testing, and preclinical support) akin to a CRO.
|
$4.32M |
$5.94
-0.17%
|
|
BUDZ
WEED, Inc.
Sangre AgroTech represents plant genomic research services, akin to contract research and development.
|
$4.08M |
$0.03
|
|
YBGJ
Yubo International Biotech Limited
Provides outsourced research/testing services and advisory functions (CRO-like capabilities).
|
$1.77M |
$0.01
|
|
ELAB
PMGC Holdings Inc.
Contract Research Organizations (CRO)-like R&D capabilities through PMGC Research Inc. for biotech development.
|
$1.63M |
$3.35
-13.12%
|
Loading company comparison...
Loading industry trends...
Loading research report...
